Vimarsana
Biggest News Aggregation in the World

Clinical Samples News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Samples. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Samples Today - Breaking & Trending Today

A Faster Way to Find Bacteria in Food, Water, and Clinical Samples - Vimarsana News

A Faster Way to Find Bacteria in Food, Water, and Clinical Samples

Based on what a test has been targeted, getting outcomes from a blood test could take anywhere from one day to a week.

Noninvasive Brain Stimulation Techniques for Catatonia - Vimarsana News

Noninvasive Brain Stimulation Techniques for Catatonia

A recent study finds noninvasive brain stimulation techniques such as ECT, rTMS, and tDCS may be helpful for patients with catatonia.

Streck introduces viral extraction kit for clinical samples - Vimarsana News

Streck introduces viral extraction kit for clinical samples

The Streck Viral Extraction Kit simplifies and decreases the time needed to isolate viral genome from clinical samples

The lasting benefits of decentralized clinical trials logistics - Vimarsana News

The lasting benefits of decentralized clinical trials logistics

The global pandemic has been a catalyst in transforming how clinical trials are run. A decentralized trial framework backed by enhanced logistics, improves patient sign-ups, and ensure trials continue uninterrupted – all benefits that can be reapplied in a post-COVID world.

Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) toAdvance Clinical Research of Infectious Diseases - Vimarsana News

Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) toAdvance Clinical Research of Infectious Diseases

Waters Corporation (NYSE:WAT) today introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method that directly detects and quantifies SARS-CoV-2 Nucleocapsid (NCAP) peptides that initial studies have shown to yield highly accurate, quantitative results.